Before Donald Trump became president-elect of the United States, I declared my support for his proposed efforts to help curb the tragic opioid abuse epidemic our nation is facing today.
A scalp-cooling system helped prevent hair loss in women with breast cancer undergoing chemotherapy, researchers said today at the San Antonio Breast Cancer Symposium.
AstraZeneca will expand its collaboration with Eli Lilly to develop an experimental Alzheimer's drug, sticking with an approach that has been a mainstay of research despite recent setbacks.
The U.S. Centers for Disease Control and Prevention and the Florida Department of Health said on Friday that the Miami Beach area was no longer considered an active Zika transmission zone.
Synergy Pharmaceuticals Inc said its experimental once-daily tablet, plecanatide, met the main goal of a late-stage study on irritable bowel syndrome patients with constipation (IBS-C), according to an analysis of preliminary data.
Cases of microcephaly in Colombia were four times higher this year than last, an increase that coincides with a widespread outbreak of Zika virus in the country, a report released on Friday said.
Publix Super Markets is recalling some of its waffle and pancake mixes because its supplier announced a milk powder in the mix may be contaminated with salmonella, My Fox 8 reported.
A Wisconsin mother who posted a photo of herself with severe face, neck and chest burns is warning other parents about the possible dangers of multitasking while carrying their babies.
Drugmaker Bristol-Myers Squibb Co will pay $19.5 million to resolve multi-state allegations that it improperly promoted a schizophrenia treatment for uses not approved by the U.S. government, New York Attorney General Eric Schneiderman said on Thursday.
It was all love and hugs for two formerly conjoined twins, who have been doing well since they left the Bronx hospital where they were separated in October and have appeared in new a video in which one sweetly coos, “Dada.”
Gradually increasing the dose of Biogen Inc's experimental Alzheimer's disease drug appeared to cause less risk of brain swelling than fixed doses, according to interim 12-month results from a small study released on Thursday.
